WallStreetZenWallStreetZen

NASDAQ: IMRN
Immuron Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their IMRN stock forecasts and price targets.

Forecast return on equity

Is IMRN forecast to generate an efficient return?

Company
-44.57%
Industry
72.37%
Market
-20.15%
IMRN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IMRN forecast to generate an efficient return on assets?

Company
-35.47%
Industry
23.4%
IMRN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IMRN earnings per share forecast

What is IMRN's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.03

IMRN revenue growth forecast

How is IMRN forecast to perform vs Biotechnology companies and vs the US market?

Company
82.7%
Industry
245.24%
Market
11.9%
IMRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMRN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMRN$1.86N/AN/A
EVGN$1.24$3.50+183.17%Strong Buy
APM$1.96N/AN/A
INTS$0.24$2.25+853.39%Strong Buy
XTLB$1.20N/AN/A
View Top Biotech Stocks

Immuron Stock Forecast FAQ

What is IMRN's earnings growth forecast for 2026-2026?

(NASDAQ: IMRN) Immuron's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.63%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.33%.

Immuron's earnings in 2025 is -$3,433,469.

In 2026, IMRN is forecast to generate -$7,018,770 in earnings, with the lowest earnings forecast at -$7,018,770 and the highest earnings forecast at -$7,018,770.

If you're new to stock investing, here's how to buy Immuron stock.

What is IMRN's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: IMRN) forecast ROE is -44.57%, which is considered weak.

What is IMRN's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: IMRN) Immuron's current Earnings Per Share (EPS) is -$0.80. In 2026, IMRN's EPS is forecast to hit -$0.03 (min: -$0.03, max: -$0.03).

What is IMRN's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: IMRN) forecast ROA is -35.47%, which is lower than the forecast US Biotechnology industry average of 23.4%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.